ATAZANAVIR CIPLA atazanavir 150 mg capsule bottle pack

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

atazanavir sulfate, Quantity: 170.85 mg (Equivalent: atazanavir, Qty 150 mg)

Доступна с:

Cipla Australia Pty Ltd

ИНН (Международная Имя):

Atazanavir sulfate

Фармацевтическая форма:

Capsule, hard

состав:

Excipient Ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; Gelatin; sodium lauryl sulfate

Администрация маршрут:

Oral

Штук в упаковке:

60 capsules, 30 capsules

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

Atazanavir is indicated for the treatment of HIV 1 infection, in combination with other antiretroviral agents. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts from controlled studies (See Clinical Trials).

Обзор продуктов:

Visual Identification: White to pale yellow granules filled in size 1 hard gelatin capsule with maroon cap & white body spin printed with Cipla 150 on cap with white ink.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Статус Авторизация:

Licence status A

Дата Авторизация:

2017-08-30